Literature DB >> 8142237

Autosomal recessive polycystic kidney disease in 15 Arab children.

T K Mattoo1, Y Khatani, B Ashraf.   

Abstract

The study includes 15 children (8 males, 7 females) with autosomal recessive polycystic kidney disease (ARPKD) whose ages at diagnosis ranged from 2 days to 7 years (median 10 months). Eleven (73.3%) patients were hypertensive on admission and 1 developed hypertension 4 months later; 5 patients became normotensive after receiving treatment for 18-36 months (mean 23.2 months). Patients were followed for a period of 1-48 months (mean 20.9 months). Glomerular filtration rate remained normal in 7 patients, improved in 4 and deteriorated in 1. Two patients died soon after diagnosis and 1 was lost to follow-up and is assumed dead. Of the 4 patients less than 6 months old at the time of diagnosis, only 1 is alive compared with 10 of 11 presenting after 6 months of age. The cumulative chance of survival from the time of diagnosis was 85% at 3 months and 77% at 6 months. The study highlights the reversible nature of hypertension in ARPKD. Survival is better in patients older than 6 months at the time of diagnosis and those surviving 6 months follow-up.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142237     DOI: 10.1007/bf00868276

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

2.  Systolic blood pressure in a population of infants in the first year of life: the Brompton study.

Authors:  M de Swiet; P Fayers; E A Shinebourne
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

3.  Autosomal recessive polycystic kidney disease.

Authors:  B S Kaplan; J Fay; V Shah; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

4.  A simple estimate of glomerular filtration rate in full-term infants during the first year of life.

Authors:  G J Schwartz; L G Feld; D J Langford
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

5.  Polycystic kidney disease in the first year of life.

Authors:  B R Cole; S B Conley; F B Stapleton
Journal:  J Pediatr       Date:  1987-11       Impact factor: 4.406

6.  Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data.

Authors:  H Kääriäinen; O Koskimies; R Norio
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

7.  Infantile polycystic disease of the liver and kidneys.

Authors:  D L Gang; J T Herrin
Journal:  Clin Nephrol       Date:  1986-01       Impact factor: 0.975

8.  Hypertension in infantile polycystic renal disease. The importance of early recognition and treatment of severe hypertension in polycystic renal disease.

Authors:  W J Rahill; M I Rubin
Journal:  Clin Pediatr (Phila)       Date:  1972-04       Impact factor: 1.168

  8 in total
  4 in total

1.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

Review 2.  Pediatric renal diseases in the Kingdom of Saudi Arabia.

Authors:  Jameela Abdulaziz Kari
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

3.  Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.

Authors:  Christian R Halvorson; Matthew S Bremmer; Stephen C Jacobs
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-06-24

4.  Outcome of Multi-Cystic Dysplastic Kidneys in Children.

Authors:  Suleiman D Mashat; Sherif M El-Desoky; Jameela Abdulaziz Kari
Journal:  Iran J Pediatr       Date:  2015-10-06       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.